Introducing

Avicena Sentinel

Fast, Accurate, Affordable, and Scalable Pathogen Screening

The most scalable rapid molecular diagnostics platform in the world, offering a unique surge capability of up to 100,000 tests daily.

Next-Generation Molecular Diagnostics

The Avicena Sentinel is the world’s most scalable rapid molecular diagnostics platform.

Available in two versions, the Sentinel ULTRA and Sentinel Mini cater to diverse testing needs, making it economically viable for both low and high-volume scenarios.

With accuracy comparable to PCR, the Avicena Sentinel outperforms in speed and affordability, while preserving the capability to screen for multiple pathogens simultaneously.

Effortless Saliva Sample Collection

Quick Saliva Sample Collection

Simply swab your mouth with our microswab to gather the optimal saliva volume.

Secure in Barcoded Sample Tube

Secure the swab in the provided barcode-labeled sample tube that contains a stabilising buffer solution.

The Sentinel Platform

Sentinel Mini

Surge capacity up to 384 hourly
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting

Sentinel ULTRA V3

Surge capacity up to 100,000 daily
Up to 10x faster than PCR
Continuous Flow Processing
Fully Automated
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting

The Future of Biosecurity

The flexible Sentinel system can rapidly adapt to test for current and emerging pathogen threats.

Human Biosecurity

Emerging Threats

Lumpy Skin Disease
Japanese Encephalitis Virus
Monkeypox
Zika Virus
Dengue
Malaria
Bioengineered Pathogens

Blood Banks

HIV
Hepatitis B
Hepatitis C

Antibiotic Resistant Pathogens

Drug-Resistant Tuberculosis
MRSA
VRE
Pseudomonas
Acinetobacter

Influenza

Human & Zoonotic influenza
Emerging Pandemic Flu Threats

Animal Biosecurity

Cattle

Lumpy Skin Disease
Foot & Mouth Disease
Brucellosis

Equine

Herpesvirus
Nipah
Hendra

Pigs

African Swine Fever
Swine Flu

Birds

Avian Flu
Psittacosis

Enforce your First Line of Defence

Rapid detection, reporting and response to disease outbreaks is the first line of defence.

Contact our team to learn what an effective and rapid implementation looks like.

Scientific Publications

Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for pandemic-scale infection surveillance

Dewhurst RE, et al. 2022.Nature, Scientific Reports. Access here: DOI.

TGA Authorised¹

Sentinel has achieved a Class 1 IVD listing on the Australian Register of Therapeutic Goods (ARTG) under the TGA.

CE-Marked Chemistry

CE-Mark for COVID test chemistry developed by Hayat Genetics, acquired by Avicena Systems.

Patent-Pending

Avicena holds several patent pending innovations that enable our groundbreaking performance.

Intended Use

The Avicena Sentinel instrument is intended for trained laboratory professionals to run isothermal amplification assays. Diagnostic use of the Sentinel requires IVD reagents and laboratory workflows which have been authorised by relevant regulatory agencies in each jurisdiction and by Avicena Systems as compatible with the instrument.